Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Chitosan (CS) surface-modified poly(d,l-lactide-co-glycolide) (PLGA) nanospheres (NS) for a siRNA delivery system were evaluated in vitro. siRNA-loaded PLGA NS were prepared by an emulsion solvent diffusion (ESD) method, and the physicochemical properties of NS were investigated. The level of targeted protein expression and siRNA uptake were examined in A549 cells. CS-modified PLGA NS exhibited much higher encapsulation efficiency than unmodified PLGA NS (plain-PLGA NS). CS-modified PLGA NS showed a positive zeta potential, while plain-PLGA NS were negatively charged. siRNA uptake studies by observation with confocal leaser scanning microscopy (CLSM) indicated that siRNA-loaded CS-modified PLGA NS were more effectively taken up by the cells than plain-PLGA NS. The efficiencies of different siRNA preparations were compared at the level of targeted protein expression. The gene-silencing efficiency of CS-modified PLGA NS was higher and more prolonged than those of plain-PLGA NS and naked siRNA. This result correlated with the CLSM studies, which may have been due to higher cellular uptake of CS-modified PLGA NS due to electrostatic interactions. It was concluded that CS-modified PLGA NS containing siRNA could provide an effective siRNA delivery system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286 · cited 1×
“may have cytotoxicity and cannot provide controlled or sustained release [21].”
Background
Cited by
Liu, J., Willför, S., & Xu, C. (2015) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2014.12.001 · Cited by 636
Polymeric nanoparticles: Promising platform for drug delivery
El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608
Chitosan and its derivatives for gene delivery
Saranya, N., Moorthi, A., Saravanan, S., Devi, M. P., & Selvamurugan, N. (2011) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2010.11.013 · Cited by 260
Carbohydrate-based amphiphilic nano delivery systems for cancer therapy
Liu, K., Jiang, X., & Hunziker, P. (2016) · Nanoscale · doi:10.1039/c6nr04489a · Cited by 186
Polysaccharide-based nucleic acid nanoformulations
Raemdonck, K., Martens, T. F., Braeckmans, K., Demeester, J., & De Smedt, S. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.002 · Cited by 182
Davoudi, Z., Peroutka-Bigus, N., Bellaire, B., Jergens, A., Wannemuehler, M., & Wang, Q. (2021) · Marine Drugs · doi:10.3390/md19050282 · Cited by 84
“tively charged cell membrane and resulted in the higher cellular uptake of nanoparticles coated with chitosan [41,42].”
BackgroundChitosan: a potential polymer for colon-specific drug delivery system
Gulbake, A., & Jain, S. K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.682148 · Cited by 81
Tahara, K. (2020) · Advanced Powder Technology · doi:10.1016/j.apt.2019.10.031 · Cited by 31
Self-citation
Metadata
- Authors
- Tahara, K., Yamamoto, H., Hirashima, N., & Kawashima, Y.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 74
- Issue
- 3
- Pages
- 421-426
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W1965425236
- Cited by
- 68
- References
- 1
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.